Veloxis Pharmaceuticals

    OverviewSuggest Edit

    Veloxis Pharmaceuticals is a biopharmaceutical company, which identifies, develops, and commercializes products that are used in transplantation and adjacent therapies. The Company's patented delivery technology, MeltDose, is designed to enhance the absorption and bioavailability of select orally administered drugs. Veloxis's lead product candidate is Envarsus XR, a once-daily dosage tablet version of tacrolimus, which is used to aid in the prophylaxis of organ rejection in transplant recipients.

    TypePublic
    Founded2002
    HQKøbenhavn, DK
    Websiteveloxis.com

    Latest Updates

    Employees (est.) (Feb 2019)54
    Cybersecurity ratingBMore

    Key People/Management at Veloxis Pharmaceuticals

    Craig Collard

    Craig Collard

    CEO
    Masaya Etoh

    Masaya Etoh

    Chairman
    Ira Duarte

    Ira Duarte

    Chief Financial Officer
    Daisuke Matsuo

    Daisuke Matsuo

    Board Member
    Ulf Meier-Kriesche

    Ulf Meier-Kriesche

    Chief Scientific Officer
    Tunde Otulana

    Tunde Otulana

    Chief Medical Officer
    Show more

    Veloxis Pharmaceuticals Office Locations

    Veloxis Pharmaceuticals has offices in København and Cary
    København, DK (HQ)
    37 Amerika Pl.
    Cary, NC, US
    1001 Winstead Dr #310
    Show all (2)

    Veloxis Pharmaceuticals Online and Social Media Presence

    Embed Graph

    Veloxis Pharmaceuticals Blogs

    With his vow to get troops out of Afghanistan and proposals that elevate the working class, Biden is eying achievements Trump talked up but failed to accomplish

    • Why the US is leaving Afghanistan • Opinion: Biden’s magical thinking on Afghanistan • Where everything is controlled by Taliban The post With his vow to get troops out of Afghanistan and proposals that elevate the working class, Biden is eying achievements Trump talked up but failed to accomplish…

    Protesters gather for a fourth night in Brooklyn Center

    The post Protesters gather for a fourth night in Brooklyn Center appeared first on Veloxis.

    Kim Potter, charged with second-degree manslaughter, posted bail Wednesday and was released from custody

    A police officer who shot and killed a Black man in a Minneapolis suburb after a traffic stop has been arrested and charged with second-degree manslaughter in the case, authorities said Wednesday. The post Kim Potter, charged with second-degree manslaughter, posted bail Wednesday and was released fr…

    Curfew called for third night in Brooklyn Center

    The post Curfew called for third night in Brooklyn Center appeared first on Veloxis.

    Transplant Therapeutics Consortium Receives Acceptance of Letter-of-Intent for iBox Scoring System as a Reasonably Likely Surrogate Endpoint from the Biomarker Qualification Program

    Transplant Therapeutics Consortium Receives Acceptance of Letter-of-Intent for iBox Scoring System as a Reasonably Likely Surrogate Endpoint from the Biomarker Qualification Program ronfrancis.gon… Mon, 06/22/2020 - 18:57 Transplant Therapeutics Consortium Receives Acceptance of Letter-of-…

    Offentliggørelse af Nasdaq Copenhagen A/S' Accept af Veloxis Pharmaceuticals A/S' Anmodning om Afnotering af Veloxis Pharmaceuticals A/S' Aktier fra Nasdaq Copenhagen A/S

    Offentliggørelse af Nasdaq Copenhagen A/S' Accept af Veloxis Pharmaceuticals A/S' Anmodning om Afnotering af Veloxis Pharmaceuticals A/S' Aktier fra Nasdaq Copenhagen A/S Greta.Jankausk… Wed, 01/29/2020 - 15:15 Offentliggørelse af Nasdaq Copenhagen A/S' Accept af Veloxis Pharmaceuticals A/…
    Show more

    Veloxis Pharmaceuticals Frequently Asked Questions

    • When was Veloxis Pharmaceuticals founded?

      Veloxis Pharmaceuticals was founded in 2002.

    • Who are Veloxis Pharmaceuticals key executives?

      Veloxis Pharmaceuticals's key executives are Craig Collard, Masaya Etoh and Ira Duarte.

    • How many employees does Veloxis Pharmaceuticals have?

      Veloxis Pharmaceuticals has 54 employees.

    • Who are Veloxis Pharmaceuticals competitors?

      Competitors of Veloxis Pharmaceuticals include Certa Therapeutics, Albumedix and Escient Pharmaceuticals.

    • Where is Veloxis Pharmaceuticals headquarters?

      Veloxis Pharmaceuticals headquarters is located at 37 Amerika Pl., København.

    • Where are Veloxis Pharmaceuticals offices?

      Veloxis Pharmaceuticals has offices in København and Cary.

    • How many offices does Veloxis Pharmaceuticals have?

      Veloxis Pharmaceuticals has 2 offices.